In a race to cure his daughter, a Google programmer enters the world of hyper-personalised drugs. "It's the sort of problem that makes doctors shake their heads. But Ipek's father, Mehmet, and mother, Tugba, hope she'll escape that fate. Thanks in part to the persistence of Mehmet, a programmer at Google, in January she became one of the first handful of US patients to receive a hyper-personalized gene medicine, tailored to treat a unique mutation." Award-winner science journalist, Erika Check Hayden, investigates in MIT Technology Review.